Incorrect	Correct
In methods section:
Of them, 6465 (37%) took part	Of these, 6465 (37%) took part
In Table 3, page 7, Column “% (95%-CI)”:
47.9 (29.0–67.4)	47.1 (29.0–66.0)
27.6 (15.9–43.5)	29.2 (17.7–44.0)
24.5 (8.9–52.0)	23.7 (10.1–46.2)
27.2 (16.4–41.5)	26.6 (16.4–40.2)
29.4 (17.4–45.2)	29.2 (17.3–45.0)
23.8 (27.1–61.4)	44.1 (28.3–61.3)
54.4 (28.8–77.9)	54.5 (31.0-76.2)
32.4 (12.2–62.4)	27.1 (10.6–53.8)
13.2 (4.5–32.5)	18.4 (5.5–46.9)
Table 3 footnote, page 7:
aCut-points for serum lipids according to Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents [36], see Table 1 bN = 692 persons 6–8 years of age at KiGGS baseline and ≥ 18 + years at KiGGS wave 2	aCut-points for serum lipids according to Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents [36], see Table 1. The percentages shown have been rounded to one decimal place, resulting in a deviation of 0.1% from 100% bN = 692 persons 6–8 years of age at KiGGS baseline and ≥ 18 + years at KiGGS wave 2
In Statistical analysis section, page 4:
“…,food diversity index at baseline and follow-up,…”	“…,food diversity index at baseline and difference from baseline to follow-up,…”
In Results section:
Table 3 presents the change in risk categories for the subgroup of children with elevated Non-HDL-C levels at baseline (N = 53). 25% (9–52%) of children with elevated non-HDL-C levels persisted in this category, 28% (16–44%) had borderline levels and 48% (29–67%) had acceptable levels at follow-up. For TC, persistence in the baseline category was 68% (Fig. 2). 42% (36–49%) of children with borderline/high TC levels at baseline remained at the same level at follow-up. 24% (27–61%) of children with elevated TC at baseline (N = 70) remained in their initial category (see Table 3). Persistence of HDL-C levels in the initial category was 74%. 44% (30–58%) of children with borderline/low HDL-C levels at baseline remained in the borderline/low category at follow-up. 13% with low HDL-C at baseline (N = 29) remained in the initial category (see Table 3).	Table 3 presents the change in risk categories for the subgroup of children with elevated non-HDL-C levels at baseline (N = 53). 24% (CI 10–46%) of children with elevated non-HDL-C levels persisted in this category, 29% (CI 18–44%) had borderline levels and 47% (CI 29–67%) had acceptable levels at follow-up. For TC, persistence in the baseline category was 68% (Fig. 2). 42% (36–49%) of children with borderline/elevated TC levels at baseline remained at the same level at follow-up. 44% (CI 28–61%) of children with elevated TC at baseline (N = 70) remained in their initial category (see Table 3). Persistence of HDL-C levels in the initial category was 74%. 44% (30–58%) of children with borderline/low HDL-C levels at baseline remained in the borderline/low category at follow-up (Fig. 2). 18% (6–47%) with low HDL-C at baseline (N = 29) remained in the initial category (see Table 3).
In Conclusion section, page 11:
A large proportion of the variance of lipid levels in young adulthood among female individuals remained unexplained by modifiable determinants requires further investigation.	A large proportion of the variance of lipid levels in young adulthood among female individuals remained unexplained by modifiable determinants, which requires further investigation.